Cascade Sunrise Consulting Launches AI Implementation and Validation Service for GMP-Regulated Businesses

Most AI specialists don't understand GMP. Most GMP specialists don't understand AI. Cascade Sunrise is built on both.
Cascade Sunrise Consulting announces a dedicated AI implementation and validation service helping pharmaceutical and biotech companies deploy local and cloud-based artificial intelligence and large language models in compliance with GMP requirements and current GAMP guidance.
BEND, Oregon - July 16, 2026 - Cascade Sunrise Consulting, a quality and compliance consultancy serving the life sciences industry, announced the launch of a dedicated AI implementation and validation service for companies operating in GMP-regulated environments. The service supports pharmaceutical, biotech, and medical device organizations seeking to adopt artificial intelligence and large language model implementation for operations while maintaining compliance with regulatory expectations.

As AI tools move from pilot projects into production quality systems, life science companies face a gap between what the technology can do and what their validation frameworks were built to handle. Traditional computer system validation approaches were not designed for systems that produce variable outputs, and regulatory guidance in this area is still maturing. The ISPE GAMP Guide on Artificial Intelligence, published in July 2025, established a risk-based framework for AI in regulated environments, and companies now need practical help translating that framework into defensible validation packages.

Cascade Sunrise Consulting's AI validation service addresses this need directly. The offering covers validation strategy and planning for local and cloud-based AI and LLM-based systems, risk assessment aligned with current GAMP guidance, performance qualification approaches suited to non-deterministic systems, and the documentation structure needed to withstand regulatory inspection.

"Life science companies are under real pressure to implement advanced systems to keep pace with rapidly evolving problems, but the cost of getting validation wrong in a GMP environment is severe," said Chase Quam, Founder of Cascade Sunrise Consulting. "Most quality teams have deep experience validating traditional software and almost none validating AI. We built this service to close that gap with an approach regulators can follow and quality teams can defend."

Chase brings roughly fifteen years of GMP experience across pharmaceutical, biotech, and diagnostics companies. He has built multiple quality systems from the ground up and qualified multiple facilities for regulatory inspection. He has experience deploying local and cloud-based artificial intelligence solutions in regulated environments.

The AI validation service is available now to companies nationwide. In addition to AI validation, Cascade Sunrise Consulting provides quality system design, startup facility and utilities validation, and support for evolving quality systems as organizations grow and their regulatory obligations change.

About Cascade Sunrise Consulting

Cascade Sunrise Consulting is a GMP consulting firm based in Bend, Oregon, serving life science companies nationwide. The firm specializes in AI implementation and validation for regulated environments, quality system design, facility and utilities validation, and evolving quality systems.

Learn more at https://cascadesunrise.consulting

Media Contact
Company Name: Cascade Sunrise Consulting
Contact Person: Chase Quam
Email: Send Email [http://www.abnewswire.com/email_contact_us.php?pr=cascade-sunrise-consulting-launches-ai-implementation-and-validation-service-for-gmpregulated-businesses]
City: Bend
State: Oregon
Country: United States
Website: http://cascadesunrise.consulting

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.